Original anti-allergy drugs predominating markets.

The sales of original branded anti-allergy drugs may be rapidly growing in the market this spring along with its seasonal demands, which are currently distributed by UCB Korea, Boryung, Handok and Yuhan while the copy products having once over half of the total market shares now remained in around 30%, showing an ongoing declining trend.

UCB Korea's Zyrtec sold about 7 billion won last year,...